Details
Sobi (Swedish Orphan Biovitrum) is an international specialty biopharmaceutical company focused on developing and delivering treatments for rare diseases. Headquartered in Sweden, the company serves patients in over 30 countries and concentrates on conditions where there is high unmet medical need.
Sobi’s portfolio includes therapies in areas such as hematology, immunology, and specialty care, with a strong emphasis on rare and complex diseases. The company also collaborates with research partners and other pharmaceutical organizations to develop and commercialize innovative treatments that improve patient outcomes and quality of life.
The company operates with a strong focus on science, patient impact, and long term medical innovation. Employees work in a highly regulated and research driven environment across R&D, clinical development, regulatory affairs, manufacturing, and commercial functions. Sobi’s culture emphasizes responsibility, collaboration, and a commitment to improving the lives of people living with rare diseases.